Answers are grounded in this paper and cite their sources.
An alternative route: The fungal metabolite FR235222, a potent inhibitor of mammalian histone deacetylase (HDAC), has been synthesized. Key steps are the preparation of unusual amino acids Ahoda and (2R,4S)-MePro. A 3D model for cyclopeptide inhibitor interaction with the HDAC active site (see picture) highlights the differences between the binding mode of small-molecule and cyclopeptide inhibitors.
No takes yet. Share an insight, caveat, or question.
Rodriquez et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: